6,7-DIMETHYL-2,3-DI(2-PYRIDYL)QUINOXALINE
₹11853.38
Product name: 6,7-DIMETHYL-2,3-DI(2-PYRIDYL)QUINOXALINE CAS: 6627-38-9 MF: C20H16N4MW: 312.37EINECS: 229-592-0 MDL Number: MFCD00006730 Synonyms: 6,7-DIMETHYL-2,3-DI(2-PYRIDYL)QUINOXALINE;6,7-Dimethyl-2,3-di(2-pyridyl)quinoxaline 98%;2,3-Bis(2-pyridinyl)-6,7-dimethylquinoxaline;2,3-Bis(2-pyridyl)-6,7-dimethylquinoxaline;6,7-Dimethyl-2,3-bis(2-pyridyl)quinoxaline;6,7-Dimethyl-2,3-bis(pyridin-2-yl)quinoxaline;6,7-Dimethyl-2,3-di(pyridin-2-yl)quinoxaline;Quinoxaline, 6,7-dimethyl-2,3-di-2-pyridinyl-
1 prices
Manufacturer Sigma-Aldrich(India) Product number 126462 Product description 6,7-Dimethyl-2,3-di(2-pyridyl)quinoxaline 98% Packaging 5G Price ₹11853.38 Updated 2022-06-14 Buy
Manufacturer
Product number
Product description
Packaging
Price
Updated
Buy
Sigma-Aldrich(India)
126462
6,7-Dimethyl-2,3-di(2-pyridyl)quinoxaline 98%
5G
₹11853.38 2022-06-14
Buy
Properties
Melting point : 191-193 °C (lit.)
CAS DataBase Reference : 6627-38-9
Safety Information
Symbol(GHS):
Signal word:
Warning
Hazard statements:
Code
Hazard statements
Hazard class
Category
Signal word
Pictogram
P-Codes
H315 Causes skin irritation
Skin corrosion/irritation
Category 2
Warning
P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation
Serious eye damage/eye irritation
Category 2A
Warning
P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation
Specific target organ toxicity, single exposure;Respiratory tract irritation
Category 3
Warning
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P271 Use only outdoors or in a well-ventilated area.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352 IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
Description
6,7-Dimethyl-2,3-di-(2-pyridyl)quinoxaline has been used as an internal standard to investigate the clinical pharmacokinetics of nelfinavir mesylate, a potent inhibitor of HIV-1 protease.
Suppliers and manufacturers
